{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T20:57:56Z","timestamp":1774213076732,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","physicamedica.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physica Medica"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ejmp.2023.102644","type":"journal-article","created":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T12:02:47Z","timestamp":1690027367000},"page":"102644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Bone marrow sparing in prostate cancer patients treated with Post-operative pelvic nodal radiotherapy \u2013 A proton versus photon comparison"],"prefix":"10.1016","volume":"112","author":[{"given":"Mariluz","family":"De Ornelas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe Carlo","family":"Iorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Bossart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto","family":"Ricardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3252-416X","authenticated-orcid":false,"given":"Crystal","family":"Seldon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Dal Pra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Butkus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10338","key":"10.1016\/j.ejmp.2023.102644_b0005","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/S0140-6736(21)01790-6","article-title":"The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology\/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial","volume":"399","author":"Pollack","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ejmp.2023.102644_b0010","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2021.07.1699","article-title":"Elective Nodal Radiotherapy for Prostate Cancer: For None, Some, or all?","volume":"111","author":"Zaorsky","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.ejmp.2023.102644_b0015","first-page":"e348","article-title":"Elective nodal radiotherapy in prostate cancer","volume":"22","author":"De Meerleer","year":"2021","journal-title":"LancetOncol"},{"key":"10.1016\/j.ejmp.2023.102644_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103497","article-title":"The Impact of Pelvic Nodal Radiotherapy on Hematologic Toxicity: A Systematic Review with Focus on Leukopenia, Lymphopenia and Future Perspectives in Prostate Cancer Treatment","volume":"168","author":"Iorio","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"10.1016\/j.ejmp.2023.102644_b0025","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ijrobp.2016.01.022","article-title":"Hematologic Toxicity in Patients Treated With Postprostatectomy Whole- Pelvis Irradiation With Different Intensity Modulated Radiation Therapy Techniques Is Not Negligible and Is Prolonged: Preliminary Results of a Longitudinal, Observational Study","volume":"95","author":"Cozzarini","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ejmp.2023.102644_b0030","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0360-3016(94)00430-S","article-title":"Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy","volume":"31","author":"Mauch","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ejmp.2023.102644_b0035","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.ijrobp.2011.09.048","article-title":"Correlation between radiation dose to 18F-FDG-PET defined active bone marrow subregions and acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy","volume":"83","author":"Rose","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ejmp.2023.102644_b0040","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/jcb.22699","article-title":"Differential effect of ionizing radiation exposure on multipotent and differentiation-restricted bone marrow mesenchymal stem cells","volume":"111","author":"Mussano","year":"2010","journal-title":"J Cell Biochem"},{"issue":"1","key":"10.1016\/j.ejmp.2023.102644_b0045","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijrobp.2016.04.009","article-title":"Using [(18)F]Fluorothymidine Imaged With Positron Emission Tomography to Quantify and Reduce Hematologic Toxicity Due to Chemoradiation Therapy for Pelvic Cancer Patients","volume":"96","author":"McGuire","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ejmp.2023.102644_b0050","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.ijrobp.2006.03.018","article-title":"Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy","volume":"66","author":"Mell","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ejmp.2023.102644_b0055","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijrobp.2014.05.041","article-title":"Fat composition changes in bone marrow during chemotherapy and radiation therapy","volume":"90","author":"Carmona","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.ejmp.2023.102644_b0060","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/jmri.24071","article-title":"Water-fat MRI for assessing changes in bone marrow composition due to radiation and chemotherapy in gynecologic cancer patients","volume":"38","author":"Bolan","year":"2013","journal-title":"J Magn Reson Imaging"},{"issue":"2","key":"10.1016\/j.ejmp.2023.102644_b0065","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.semradonc.2019.12.003","article-title":"Lymphocyte-Sparing Radiotherapy: The Rationale for Protecting Lymphocyte-rich Organs When Combining Radiotherapy With Immunotherapy","volume":"30","author":"Lambin","year":"2020","journal-title":"Semin Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ejmp.2023.102644_b0070","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-019-1223-2","article-title":"Leukotoxicity after moderately Hypofractionated radiotherapy versus conventionally fractionated dose escalated radiotherapy for localized prostate Cancer: a secondary analysis from a randomized study","volume":"14","author":"Sanguineti","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ejmp.2023.102644_b0075","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1002\/1097-0142(19850501)55:9+<2086::AID-CNCR2820551409>3.0.CO;2-1","article-title":"Biologic basis for altered fractionation schemes","volume":"55","author":"Withers","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.ejmp.2023.102644_b0080","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/0360-3016(87)90046-0","article-title":"Fractionation and dose rate effects in mice: a model for bone marrow transplantation in man","volume":"13","author":"Tarbell","year":"1987","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2023.102644_b0085","doi-asserted-by":"crossref","unstructured":"MacLennan IC, Kay HE. Analysis of treatment in childhood leukemia. IV. The critical association between dose fractionation and immunosuppression induced by cranial irradiation. Cancer 1978;41:108\u2013111. https:\/\/doi.org\/10.1002\/1097-0142(197801)41:1<108::aid-cncr2820410116>3.0.co;2-z.","DOI":"10.1002\/1097-0142(197801)41:1<108::AID-CNCR2820410116>3.0.CO;2-Z"},{"key":"10.1016\/j.ejmp.2023.102644_b0090","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2307\/3577549","article-title":"Radiosensitivity of CD4 or CD8 positive human T-lymphocytes by an in vitro colony formation assay","volume":"123","author":"Nakamura","year":"1990","journal-title":"Radiat Res"},{"issue":"3","key":"10.1016\/j.ejmp.2023.102644_b0095","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ijrobp.2016.11.027","article-title":"Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2)","volume":"97","author":"Mell","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2023.102644_b0100","doi-asserted-by":"crossref","unstructured":"Noy M, Soliman D, Karp M, Studensky M, Abramowitz M, Dogan N, et al. PTV margins for postoperative pelvic nodal radiotherapy (PNRT) using a dose accumulation workflow. Radiother Oncol 2021, ESTRO 2021. PO-1553.","DOI":"10.1016\/S0167-8140(21)08004-X"},{"issue":"3","key":"10.1016\/j.ejmp.2023.102644_b0105","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1002\/mp.13390","article-title":"Report of the AAPM TG-256 on the relative biological effectiveness of proton beams in radiation therapy","volume":"46","author":"Paganetti","year":"2019","journal-title":"Med Phys"},{"key":"10.1016\/j.ejmp.2023.102644_b0110","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4103\/0971-6203.103606","article-title":"Homogeneity Index: An objective tool for assessment of conformal radiation treatments","volume":"37","author":"Kataria","year":"2012","journal-title":"J Med Phys"},{"key":"10.1016\/j.ejmp.2023.102644_b0115","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/0360-3016(89)90972-3","article-title":"Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method","volume":"16","author":"Kutcher","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2023.102644_b0120","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0360-3016(91)90173-2","article-title":"Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations","volume":"21","author":"Kutcher","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2023.102644_b0125","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2307\/3583506","article-title":"Complication probability as assessed from dose-volume histograms","volume":"8","author":"Lyman","year":"1985","journal-title":"Radiat Res Suppl"},{"key":"10.1016\/j.ejmp.2023.102644_b0130","first-page":"1100","article-title":"A Generalized Concept of Equivalent Uniform Dose (EUD)","volume":"26","author":"Niemierko","year":"1999","journal-title":"Med Phys"},{"key":"10.1016\/j.ejmp.2023.102644_b0135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1088\/0031-9155\/53\/1\/002","article-title":"A new formula for normal tissue complication probability (NTCP) as a function of equivalent uniform dose (EUD)","volume":"53","author":"Luxton","year":"2008","journal-title":"Phys Med Biol"},{"issue":"9","key":"10.1016\/j.ejmp.2023.102644_b0140","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.ejmp.2016.08.007","article-title":"NTCP modeling analysis of acute hematologic toxicity in whole pelvic radiation therapy for gynecologic malignancies - A dosimetric comparison of IMRT and spot-scanning proton therapy (SSPT)","volume":"32","author":"Yoshimura","year":"2016","journal-title":"Phys Med"},{"key":"10.1016\/j.ejmp.2023.102644_b0145","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ijrobp.2011.12.072","article-title":"Normal tissue complication probability modeling of acute hematologic toxicity in patients treated with intensity-modulated radiation therapy for squamous cell carcinoma of the anal canal","volume":"84","author":"Bazan","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ejmp.2023.102644_b0150","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.ijrobp.2013.09.017","article-title":"Impact of chemotherapy on normal tissue complication probability models of acute hematologic toxicity in patients receiving pelvic intensity modulated radiation therapy","volume":"87","author":"Bazan","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ejmp.2023.102644_b0155","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.ijrobp.2021.07.1695","article-title":"The Influence of Severe Radiation-Induced Lymphopenia on Overall Survival in Solid Tumors: A Systematic Review and Meta-Analysis","volume":"111","author":"Damen","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2023.102644_b0160","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.critrevonc.2018.01.003","article-title":"A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors","volume":"123","author":"Venkatesulu","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ejmp.2023.102644_b0165","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.adro.2019.01.005","article-title":"Radiation-related Lymphopenia after Pelvic Nodal Irradiation for Prostate Cancer","volume":"4","author":"Schad","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ejmp.2023.102644_b0170","unstructured":"M. Miszczyk W. Majewski Hematologic Toxicity of Conformal Radiotherapy and Intensity Modulated Radiotherapy in Prostate and Bladder Cancer Patients Asian Pac J Cancer Prev 19 2018 2803 2806 https:\/\/doi.org\/10.22034\/APJCP.2018.19.10.2803."},{"issue":"10","key":"10.1016\/j.ejmp.2023.102644_b0175","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00066-015-0841-3","article-title":"Early hematologic changes during prostate cancer radiotherapy predictive for late urinary and bowel toxicityFr\u00fche h\u00e4matologische Ver\u00e4nderungen w\u00e4hrend der Radiotherapie beim Prostatakarzinom pr\u00e4diktiv f\u00fcr sp\u00e4te Miktions- und Darmbeschwerden","volume":"191","author":"Pinkawa","year":"2015","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ejmp.2023.102644_b0180","doi-asserted-by":"crossref","first-page":"S332","DOI":"10.1016\/S0167-8140(18)30937-X","article-title":"PV-0627: Hematologic toxicity after whole-pelvis irradiation: results of a longitudinal observational study","volume":"127","author":"Rancati","year":"2018","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ejmp.2023.102644_b0185","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.radonc.2015.11.020","article-title":"Dose-volume effects for pelvic bone marrow in predicting hematological toxicity in prostate cancer radiotherapy with pelvic node irradiation","volume":"118","author":"Sini","year":"2016","journal-title":"Radiother Oncol"},{"issue":"170","key":"10.1016\/j.ejmp.2023.102644_b0190","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.radonc.2022.02.030","article-title":"Impact of radiotherapy parameters on the risk of lymphopenia in urological tumors: a systematic review of the literature","volume":"2022","author":"Danckaert","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejmp.2023.102644_b0195","doi-asserted-by":"crossref","unstructured":"T.J. Whitaker D.M. Routman H. Schultz W.S. Harmsen K.S. Corbin W.W. Wong et al. IMPT versus VMAT for Pelvic Nodal Irradiation in Prostate Cancer: A Dosimetric Comparison Int J Part Ther 5 2019 11 23 https:\/\/doi.org\/10.14338\/IJPT-18-00048.1.","DOI":"10.14338\/IJPT-18-00048.1"},{"issue":"1","key":"10.1016\/j.ejmp.2023.102644_b0200","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-016-0761-0","article-title":"Treatment planning comparison of IMPT, VMAT and 4\u03c0 radiotherapy for prostate cases","volume":"12","author":"Tran","year":"2017","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ejmp.2023.102644_b0205","doi-asserted-by":"crossref","first-page":"22","DOI":"10.14338\/IJPT.13-00003.1","article-title":"Proton Therapy vs. VMAT for Prostate Cancer: A Treatment Planning Study","volume":"1","author":"Rana","year":"2014","journal-title":"Int J Part Ther"},{"issue":"3","key":"10.1016\/j.ejmp.2023.102644_b0210","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.radonc.2015.05.005","article-title":"Bone marrow sparing in intensity modulated proton therapy for cervical cancer: Efficacy and robustness under range and setup uncertainties","volume":"115","author":"Dinges","year":"2015","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ejmp.2023.102644_b0215","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s13566-017-0329-0","article-title":"Absolute volume of active bone marrow and total bone marrow spared in anal cancer patients using intensity modulated proton versus volumetric arc therapy","volume":"7","author":"Prasad","year":"2018","journal-title":"J Radiat Oncol"},{"issue":"3","key":"10.1016\/j.ejmp.2023.102644_b0220","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.radonc.2015.10.027","article-title":"Scanning proton beam therapy reduces normal tissue exposure in pelvic radiotherapy for anal cancer","volume":"117","author":"Anand","year":"2015","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.ejmp.2023.102644_b0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14338\/IJPT-21-00003.1","article-title":"Bone Marrow Suppression during Postoperative Radiation for Bladder Cancer and Comparative Benefit of Proton Therapy\u2014Phase 2 Trial Secondary Analysis","volume":"8","author":"Press","year":"2022","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.ejmp.2023.102644_b0230","doi-asserted-by":"crossref","unstructured":"T. Meier A. Mascia E. Wolf J. Kharofa Dosimetric Comparison of Intensity-Modulated Proton Therapy and Volumetric-Modulated Arc Therapy in Anal Cancer Patients and the Ability to Spare Bone Marrow Int J Part Ther 4 2017 11 17 https:\/\/doi.org\/10.14338\/IJPT-17-00017.","DOI":"10.14338\/IJPT-17-00017"},{"key":"10.1016\/j.ejmp.2023.102644_b0235","first-page":"3","article-title":"Protons offer reduced bone marrow, small bowel, and urinary bladder exposure for patients receiving neoadjuvant radiotherapy for resectable rectal cancer","volume":"5","author":"Colaco","year":"2014","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.ejmp.2023.102644_b0240","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ijrobp.2019.05.064","article-title":"Impact of Radiation Dose to the Host Immune System on Tumor Control and Survival for Stage III Non-Small Cell Lung Cancer Treated with Definitive Radiation Therapy","volume":"105","author":"Ladbury","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2023.102644_b0245","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.phro.2022.07.006","article-title":"Lymphocyte-sparing pelvic radiotherapy for prostate cancer: An in-silico study","volume":"23","author":"Bar\u00e9","year":"2022","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.ejmp.2023.102644_b0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/123241","article-title":"Inflammation and immunity in radiation damage to the gut mucosa","volume":"2013","author":"Fran\u00e7ois","year":"2013","journal-title":"Biomed Res Int"}],"container-title":["Physica Medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1120179723001217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1120179723001217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:57:25Z","timestamp":1761105445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1120179723001217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":50,"alternative-id":["S1120179723001217"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmp.2023.102644","relation":{},"ISSN":["1120-1797"],"issn-type":[{"value":"1120-1797","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone marrow sparing in prostate cancer patients treated with Post-operative pelvic nodal radiotherapy \u2013 A proton versus photon comparison","name":"articletitle","label":"Article Title"},{"value":"Physica Medica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmp.2023.102644","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Associazione Italiana di Fisica Medica e Sanitaria. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102644"}}